<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        
        
        
        <link rel="shortcut icon" href="../../img/favicon.ico">
        <title>Non ST Segment Elevation Acute Coronary Syndromes (NSTEACS) - MediWiki</title>
        <link href="../../css/bootstrap.min.css" rel="stylesheet">
        <link href="../../css/font-awesome.min.css" rel="stylesheet">
        <link href="../../css/base.css" rel="stylesheet">
        <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.8.0/styles/color-brewer.min.css">
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.8.0/highlight.min.js"></script>
        <script>hljs.highlightAll();</script> 
    </head>

    <body>
        <div class="navbar fixed-top navbar-expand-lg navbar-dark bg-primary">
            <div class="container">
                <a class="navbar-brand" href="../..">MediWiki</a>
                <!-- Expander button -->
                <button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#navbar-collapse">
                    <span class="navbar-toggler-icon"></span>
                </button>

                <!-- Expanded navigation -->
                <div id="navbar-collapse" class="navbar-collapse collapse">
                        <!-- Main navigation -->
                        <ul class="nav navbar-nav">
                            <li class="navitem">
                                <a href="../../Basic%20Clinical%20Sciences.html" class="nav-link">Basic Clinical Sciences</a>
                            </li>
                            <li class="navitem">
                                <a href="../../Internal%20Medicine.html" class="nav-link">Internal Medicine</a>
                            </li>
                            <li class="navitem">
                                <a href="../../Surgery.html" class="nav-link">Surgery</a>
                            </li>
                            <li class="navitem">
                                <a href="../../Psychiatry.html" class="nav-link">Psychiatry</a>
                            </li>
                            <li class="navitem">
                                <a href="../../Critical%20Care.html" class="nav-link">Critical Care</a>
                            </li>
                        </ul>

                    <ul class="nav navbar-nav ml-auto">
                        <li class="nav-item">
                            <a href="#" class="nav-link" data-toggle="modal" data-target="#mkdocs_search_modal">
                                <i class="fa fa-search"></i> Search
                            </a>
                        </li>
                            <li class="nav-item">
                                <a rel="prev" href="Myocarditis.html" class="nav-link">
                                    <i class="fa fa-arrow-left"></i> Previous
                                </a>
                            </li>
                            <li class="nav-item">
                                <a rel="next" href="Orthostatic%20Hypotension.html" class="nav-link">
                                    Next <i class="fa fa-arrow-right"></i>
                                </a>
                            </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="container">
            <div class="row">
                    <div class="col-md-3"><div class="navbar-light navbar-expand-md bs-sidebar hidden-print affix" role="complementary">
    <div class="navbar-header">
        <button type="button" class="navbar-toggler collapsed" data-toggle="collapse" data-target="#toc-collapse" title="Table of Contents">
            <span class="fa fa-angle-down"></span>
        </button>
    </div>

    
    <div id="toc-collapse" class="navbar-collapse collapse card bg-secondary">
        <ul class="nav flex-column">
            
            <li class="nav-item" data-level="2"><a href="#background" class="nav-link">Background</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="1"><a href="#unstable-angina" class="nav-link">Unstable Angina</a>
              <ul class="nav flex-column">
            <li class="nav-item" data-level="2"><a href="#background_1" class="nav-link">Background</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#pathology" class="nav-link">Pathology</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#clinical-features" class="nav-link">Clinical features</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#diagnostic-criteria" class="nav-link">Diagnostic criteria</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#investigations" class="nav-link">Investigations</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#management" class="nav-link">Management</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#prognosis" class="nav-link">Prognosis</a>
              <ul class="nav flex-column">
              </ul>
            </li>
              </ul>
            </li>
            
            <li class="nav-item" data-level="1"><a href="#non-st-elevated-myocardial-infarction" class="nav-link">Non-ST elevated myocardial infarction</a>
              <ul class="nav flex-column">
            <li class="nav-item" data-level="2"><a href="#background_2" class="nav-link">Background</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#pathology_1" class="nav-link">Pathology</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#clinical-features_1" class="nav-link">Clinical features</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#diagnostic-criteria_1" class="nav-link">Diagnostic criteria</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#investigations_1" class="nav-link">Investigations</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#management_1" class="nav-link">Management</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#prognosis_1" class="nav-link">Prognosis</a>
              <ul class="nav flex-column">
              </ul>
            </li>
              </ul>
            </li>
        </ul>
    </div>
</div></div>
                    <div class="col-md-9" role="main">

<h2 id="background">Background</h2>
<p><strong>TIMI (Thrombolysis in MI) score mnemonic: AMERICA - Used in UA or NSTEMI</strong></p>
<ul>
<li>Age (&gt;65)</li>
<li>Markers (elevated)</li>
<li>ECG changes (ST-depression in initial ECG)</li>
<li>Risk factors (3+ CHD)</li>
<li>Ischaemic chest pain (2+ Events in last 24h)</li>
<li>Coronary stenosis (&gt;50%)</li>
<li>Aspirin (in last 7 days)</li>
</ul>
<p>TIMI determines the aggressiveness of therapy:</p>
<ul>
<li>â‰¥3 - Early invasive strategy - coronary angiography + revascularisation w/ PCI or CABG</li>
<li>&lt;3 - stress testing +/- invasive testing</li>
</ul>
<p><strong>Risk factors include:</strong></p>
<p>Hypercholesterolemia, Hypertension,  Diabetes Mellitus,  Cigarette smoking,  Positive family history,  Obesity</p>
<hr />
<h1 id="unstable-angina">Unstable Angina</h1>
<h2 id="background_1">Background</h2>
<ul>
<li>The distinction between unstable angina and NSTEMI is based entirely on cardiac enzymes. The latter has elevation of troponin or creatine kinase-MB (CK-MB).
Both unstable angina and NSTEMI lack ST-segment elevations and pathologic Q waves.</li>
<li>Unstable angina has a higher risk of MI and death than stable angina, and patients with this diagnosis should be hospitalized. Its management is encompassed in Acute Coronary Syndromes</li>
</ul>
<h2 id="pathology">Pathology</h2>
<ul>
<li>Pathophysiology<ul>
<li>With unstable angina, oxygen demand is unchanged. Supply is decreased secondary to reduced resting coronary flow. This is in contrast to stable angina,  which is due to increased demand.</li>
<li>Unstable angina is significant because it indicates <strong>stenosis that has enlarged via thrombosis,</strong> hemorrhage, or plaque rupture. It may lead to total occlusion of a coronary vessel. - <em>i.e. a clot in the process of being formed</em></li>
</ul>
</li>
</ul>
<h2 id="clinical-features">Clinical features</h2>
<ul>
<li>The following patients may be said to have unstable angina<ul>
<li>Patients with chronic angina with increasing frequency, duration, or intensity of chest pain</li>
<li>Patients with new-onset angina that is severe and worsening</li>
<li>Patients with angina at rest</li>
</ul>
</li>
</ul>
<h2 id="diagnostic-criteria">Diagnostic criteria</h2>
<ul>
<li>Perform a diagnostic workup to exclude MI in all patients.<ul>
<li>Perform ECG:<ul>
<li><strong>Does NOT show ST elevation in Unstable Angina and NSTEMI</strong></li>
</ul>
</li>
<li>Perform Serial troponins:<ul>
<li>NSTEMI will demonstrate rising serial trops</li>
</ul>
</li>
</ul>
</li>
<li>Patients with unstable angina have a higher risk of adverse events during stress testing. These patients should be stabilized with medical management before stress testing or should undergo cardiac catheterization initially.</li>
</ul>
<h2 id="investigations">Investigations</h2>
<h2 id="management">Management</h2>
<p><em>MONABASH</em> </p>
<ul>
<li>Hospital admission on a floor with continuous cardiac monitoring<ul>
<li>Establish IV
access and give supplemental oxygen if patients are hypoxic. Provide pain control with nitrates (below) and opioids if pain refractory to nitrate therapy alone.</li>
</ul>
</li>
<li>
<p>Aggressive medical management is indicatedâ€”<strong>treat as in MI except for
fibrinolysis.</strong> Mortality-lowering therapy includes dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor, heparin, and Î²-blockers.</p>
<ul>
<li>Dual antiplatelet therapy<ul>
<li>Aspirin (325-mg dose) - <em>this has usually been given in the ambulance, and should not be repeated</em></li>
<li>P2Y12 inhibitor (clopidogrel 300mg loading dose, ticagrelor, prasugrel)<ul>
<li>Hold off clopidogrel if surgery is planned</li>
<li>The most commonly used agent is clopidogrelâ€”shown to reduce the incidence of MI in patients with unstable angina compared with aspirin alone in the CURE trial.</li>
<li>This benefit persists whether the patient undergoes revascularization with PCI or not.</li>
<li>This may be altered however, according to the bleeding risk of each patient.</li>
<li>The PLATO trial showed that ticagrelor had a reduced risk of death, MI, or stroke compared to clopidogrel when used for ACS, without an elevated risk of bleeding.</li>
<li>Prasugrel has the highest risk of bleeding and is the least commonly used, contraindicated if &lt;60kg, &gt;75y/o or previous stroke/TIA.</li>
</ul>
</li>
<li>Patients presenting with unstable angina should generally be treated with aspirin and clopidogrel for 9 to 12 months, in accordance with the CURE trial.</li>
</ul>
</li>
<li>Parenteral anticoagulation<ul>
<li>Severe kidney impairment â†’ Unfractionated heparin IV 60U/kg</li>
<li>Otherwise â†’ LMWH (enoxaparin)<ul>
<li>Lowâ€“molecular-weight heparin (LMWH) is superior to unfractionated heparin.<ul>
<li>Goal is to prevent progression or development of a clot</li>
<li>Should be continued for at least 48 hours</li>
<li>Enoxaparin is the drug of choice based on clinical trials (ESSENCE trial)</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>Î²-Blockersâ€”first-line therapy if there are no contraindications - use atenolol or metoprolol</li>
<li>Glycoprotein IIb/IIIa inhibitors (abciximab, tirofiban, eptifibatide) can be helpful adjuncts, if patient is undergoing PCI or has an NSTEMI</li>
<li>Morphine is controversialâ€”provides good pain relief but may mask worsening symptoms</li>
<li>Oxygen if patient is hypoxic</li>
<li>Nitrates are first-line therapy for chest pain â†’ Monitor for hypotension (e.g. if preload dependent or LVF)</li>
<li>High-intensity statin (atorvastatin 40 or 80 mg) started within 4 days of ACS can reduce risk of recurrent MI or stroke</li>
<li>ACEi to be started within 24h of admission (unless haemodynamically unstable or hypotensive)</li>
<li>
<p>Replacement of deficient electrolytes, especially K+ and Mg2+, to lower arrhythmia risk</p>
<p><em>Aspirin and LMW heparin (clexane, enoxaparin) are mainstay
Can use GP2b3a inhibitors (abciximab, tirofiban)</em> </p>
</li>
</ul>
</li>
<li>
<p>Cardiac catheterization/revascularization</p>
<ul>
<li>More than 90% of patients improve with the above medical regimen within 1 to 2 days.</li>
<li>The choice of invasive management (early catheterization/revascularization within 48 hours) versus conservative management (catheterization/revascularization only if medical therapy fails) is controversial.<ul>
<li>If patient responds to medical therapy, perform a stress test to assess need for   catheterization/revascularization.</li>
<li>Many patients with UA that is controlled with medical therapy eventually require revascularization.</li>
<li>If medical therapy fails to improve symptoms and/or ECG changes indicative of ischemia persist after 48 hours, then proceed directly to catheterization/revascularization.</li>
<li>Additional indications for PCI include hemodynamic instability, ventricular arrhythmias, and new mitral regurgitation (MR) or new septal defect.</li>
<li>
<p>The TIMI risk score can be used to guide the decision on conservative versus more aggressive treatment.</p>
<p><em>aim to stop formation of thrombus over atherosclerotic plaque, etc.</em></p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>After the acute treatment</p>
<ul>
<li>DAPT for 12 months - Aspirin should be used indefinitely, and clopidogrel should be stopped</li>
<li>Statins to be continued</li>
<li>Beta blockers to be continued (atenolol, metoprolol) unless LVF (Bisoprolol, Carvedilol, Nebivolol, metoprolol succinate)</li>
<li>ACEi/ARB</li>
<li>Reduce risk factors<ul>
<li>Smoking cessation, weight loss</li>
<li>Treat diabetes, HTN</li>
<li>Treat hyperlipidemiaâ€”patients with any form of CAD should be started on an</li>
<li>HMG-CoA reductase inhibitor regardless of LDL level. Clinical trials of statins
have shown the efficacy of such therapy for secondary prevention in CAD (see
Quick Hit on CARE trial)</li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="prognosis">Prognosis</h2>
<hr />
<h1 id="non-st-elevated-myocardial-infarction">Non-ST elevated myocardial infarction</h1>
<h2 id="background_2">Background</h2>
<h2 id="pathology_1">Pathology</h2>
<h2 id="clinical-features_1">Clinical features</h2>
<h2 id="diagnostic-criteria_1">Diagnostic criteria</h2>
<ul>
<li>ECG<ul>
<li>ST depression (or no change on ECG)</li>
</ul>
</li>
<li>Troponin or CK serially<ul>
<li>troponin and CK will rise</li>
</ul>
</li>
</ul>
<h2 id="investigations_1">Investigations</h2>
<h2 id="management_1">Management</h2>
<ul>
<li><strong>Same as</strong> ../../..//IM/Cardiology/Non-ST%20Segment%20Elevation%20Acute%20Coronary%20Syndromes%20(NSTEACS).md../../..//IM/Cardiology/Non-ST%20Segment%20Elevation%20Acute%20Coronary%20Syndromes%20(NSTEACS).md<a href="#Unstable%20Angina">Unstable Angina</a><ul>
<li>DAPT (Aspirin + Clopidogrel)</li>
<li>Statins (High dose, within 48h)</li>
<li>beta-blockers (Atenolol, metoprolol, unless LVF)</li>
<li>ACEi, Spironolactone</li>
<li>LMWH preferred (Heparin if severe renal failure)</li>
<li>GpIIb-IIIa inhibitors (tirofiban, abciximab) if going for a PCI</li>
<li>Morphine, Oxygen, Nitrates â†’ Do not give if hypotensive or at risk of postural hypotension</li>
</ul>
</li>
<li>Percutaneous catheterisation<ul>
<li>stops thrombus formation over atherosclerotic plaque</li>
</ul>
</li>
</ul>
<h2 id="prognosis_1">Prognosis</h2></div>
            </div>
        </div>

        <footer class="col-md-12">
            <hr>
                <p>Copyright &copy; 2021 Weber Liu</p>
            <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a>.</p>
        </footer>
        <script src="../../js/jquery-3.6.0.min.js"></script>
        <script src="../../js/bootstrap.min.js"></script>
        <script>
            var base_url = "../..",
                shortcuts = {"help": 191, "next": 78, "previous": 80, "search": 83};
        </script>
        <script src="../../js/base.js"></script>
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
        <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
        <script src="../../search/main.js"></script>

        <div class="modal" id="mkdocs_search_modal" tabindex="-1" role="dialog" aria-labelledby="searchModalLabel" aria-hidden="true">
    <div class="modal-dialog modal-lg">
        <div class="modal-content">
            <div class="modal-header">
                <h4 class="modal-title" id="searchModalLabel">Search</h4>
                <button type="button" class="close" data-dismiss="modal"><span aria-hidden="true">&times;</span><span class="sr-only">Close</span></button>
            </div>
            <div class="modal-body">
                <p>From here you can search these documents. Enter your search terms below.</p>
                <form>
                    <div class="form-group">
                        <input type="search" class="form-control" placeholder="Search..." id="mkdocs-search-query" title="Type search term here">
                    </div>
                </form>
                <div id="mkdocs-search-results" data-no-results-text="No results found"></div>
            </div>
            <div class="modal-footer">
            </div>
        </div>
    </div>
</div><div class="modal" id="mkdocs_keyboard_modal" tabindex="-1" role="dialog" aria-labelledby="keyboardModalLabel" aria-hidden="true">
    <div class="modal-dialog">
        <div class="modal-content">
            <div class="modal-header">
                <h4 class="modal-title" id="keyboardModalLabel">Keyboard Shortcuts</h4>
                <button type="button" class="close" data-dismiss="modal"><span aria-hidden="true">&times;</span><span class="sr-only">Close</span></button>
            </div>
            <div class="modal-body">
              <table class="table">
                <thead>
                  <tr>
                    <th style="width: 20%;">Keys</th>
                    <th>Action</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td class="help shortcut"><kbd>?</kbd></td>
                    <td>Open this help</td>
                  </tr>
                  <tr>
                    <td class="next shortcut"><kbd>n</kbd></td>
                    <td>Next page</td>
                  </tr>
                  <tr>
                    <td class="prev shortcut"><kbd>p</kbd></td>
                    <td>Previous page</td>
                  </tr>
                  <tr>
                    <td class="search shortcut"><kbd>s</kbd></td>
                    <td>Search</td>
                  </tr>
                </tbody>
              </table>
            </div>
            <div class="modal-footer">
            </div>
        </div>
    </div>
</div>

    </body>
</html>
